In RCC, SPOP exerts oncogenic activity by targeting the tumor suppressor PTEN (10), and analysis of The Cancer Genome Atlas revealed similar patterns of SPOP and PTEN alterations in KIRC and SKCM (Supplemental Figure 1I). This evidence concerns the gene PTEN and renal cell carcinoma.